nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Prednisone—prostate cancer	0.371	1	CpDpCtD
Sumatriptan—SLCO1A2—Estrone—prostate cancer	0.0352	0.0869	CbGbCtD
Sumatriptan—SLCO1B1—Cabazitaxel—prostate cancer	0.034	0.0839	CbGbCtD
Sumatriptan—SLCO1B1—Estrone—prostate cancer	0.0332	0.082	CbGbCtD
Sumatriptan—ABCG2—Cabazitaxel—prostate cancer	0.027	0.0667	CbGbCtD
Sumatriptan—ABCG2—Estrone—prostate cancer	0.0264	0.0652	CbGbCtD
Sumatriptan—SLCO1A2—Conjugated Estrogens—prostate cancer	0.023	0.0569	CbGbCtD
Sumatriptan—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0217	0.0537	CbGbCtD
Sumatriptan—SLCO1A2—Estradiol—prostate cancer	0.0202	0.0499	CbGbCtD
Sumatriptan—SLCO1B1—Estradiol—prostate cancer	0.0191	0.0471	CbGbCtD
Sumatriptan—SLCO1A2—Prednisone—prostate cancer	0.0174	0.0429	CbGbCtD
Sumatriptan—ABCG2—Conjugated Estrogens—prostate cancer	0.0173	0.0426	CbGbCtD
Sumatriptan—ABCG2—Mitoxantrone—prostate cancer	0.0157	0.0388	CbGbCtD
Sumatriptan—ABCG2—Estradiol—prostate cancer	0.0151	0.0374	CbGbCtD
Sumatriptan—ABCB1—Estramustine—prostate cancer	0.0148	0.0365	CbGbCtD
Sumatriptan—ABCG2—Etoposide—prostate cancer	0.00989	0.0244	CbGbCtD
Sumatriptan—ABCB1—Cabazitaxel—prostate cancer	0.00973	0.024	CbGbCtD
Sumatriptan—ABCB1—Estrone—prostate cancer	0.00951	0.0235	CbGbCtD
Sumatriptan—ABCG2—Docetaxel—prostate cancer	0.00905	0.0224	CbGbCtD
Sumatriptan—ABCB1—Ethinyl Estradiol—prostate cancer	0.00848	0.0209	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—prostate cancer	0.00675	0.0167	CbGbCtD
Sumatriptan—ABCB1—Conjugated Estrogens—prostate cancer	0.00622	0.0154	CbGbCtD
Sumatriptan—ABCB1—Mitoxantrone—prostate cancer	0.00565	0.014	CbGbCtD
Sumatriptan—ABCB1—Estradiol—prostate cancer	0.00546	0.0135	CbGbCtD
Sumatriptan—ABCB1—Prednisone—prostate cancer	0.0047	0.0116	CbGbCtD
Sumatriptan—ABCB1—Etoposide—prostate cancer	0.00357	0.00881	CbGbCtD
Sumatriptan—ABCB1—Docetaxel—prostate cancer	0.00326	0.00806	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—prostate cancer	0.00243	0.00601	CbGbCtD
Sumatriptan—Melatonin—CALR—prostate cancer	0.0011	0.352	CrCbGaD
Sumatriptan—Melatonin—CYP1B1—prostate cancer	0.000239	0.0769	CrCbGaD
Sumatriptan—Melatonin—MPO—prostate cancer	0.000215	0.0692	CrCbGaD
Sumatriptan—Eletriptan—CYP2A6—prostate cancer	0.000212	0.0683	CrCbGaD
Sumatriptan—Almotriptan—CYP2E1—prostate cancer	0.000194	0.0623	CrCbGaD
Sumatriptan—Almotriptan—CYP2C19—prostate cancer	0.000192	0.0617	CrCbGaD
Sumatriptan—Melatonin—CYP19A1—prostate cancer	0.000175	0.0564	CrCbGaD
Sumatriptan—Melatonin—ESR1—prostate cancer	0.000161	0.0519	CrCbGaD
Sumatriptan—Eletriptan—CYP2C19—prostate cancer	0.000149	0.048	CrCbGaD
Sumatriptan—Melatonin—CYP2C19—prostate cancer	0.000129	0.0417	CrCbGaD
Sumatriptan—Melatonin—CYP1A1—prostate cancer	0.000129	0.0415	CrCbGaD
Sumatriptan—Almotriptan—CYP3A4—prostate cancer	0.000122	0.0392	CrCbGaD
Sumatriptan—Eletriptan—CYP3A4—prostate cancer	9.5e-05	0.0306	CrCbGaD
Sumatriptan—Nervous system disorder—Capecitabine—prostate cancer	2.31e-05	0.000145	CcSEcCtD
Sumatriptan—Vertigo—Prednisone—prostate cancer	2.31e-05	0.000145	CcSEcCtD
Sumatriptan—Haemorrhage—Epirubicin—prostate cancer	2.31e-05	0.000145	CcSEcCtD
Sumatriptan—Thrombocytopenia—Capecitabine—prostate cancer	2.3e-05	0.000144	CcSEcCtD
Sumatriptan—Syncope—Prednisone—prostate cancer	2.3e-05	0.000144	CcSEcCtD
Sumatriptan—Tachycardia—Capecitabine—prostate cancer	2.3e-05	0.000144	CcSEcCtD
Sumatriptan—Hypoaesthesia—Epirubicin—prostate cancer	2.3e-05	0.000144	CcSEcCtD
Sumatriptan—Skin disorder—Capecitabine—prostate cancer	2.29e-05	0.000143	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—prostate cancer	2.28e-05	0.000143	CcSEcCtD
Sumatriptan—Hyperhidrosis—Capecitabine—prostate cancer	2.27e-05	0.000143	CcSEcCtD
Sumatriptan—Hypotension—Docetaxel—prostate cancer	2.27e-05	0.000142	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—prostate cancer	2.27e-05	0.000142	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—prostate cancer	2.27e-05	0.000142	CcSEcCtD
Sumatriptan—Loss of consciousness—Prednisone—prostate cancer	2.26e-05	0.000142	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—prostate cancer	2.24e-05	0.000141	CcSEcCtD
Sumatriptan—Nausea—Estradiol—prostate cancer	2.24e-05	0.000141	CcSEcCtD
Sumatriptan—Vomiting—Mitoxantrone—prostate cancer	2.24e-05	0.00014	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—prostate cancer	2.23e-05	0.00014	CcSEcCtD
Sumatriptan—Convulsion—Prednisone—prostate cancer	2.22e-05	0.00014	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—prostate cancer	2.22e-05	0.000139	CcSEcCtD
Sumatriptan—Hypertension—Prednisone—prostate cancer	2.22e-05	0.000139	CcSEcCtD
Sumatriptan—Rash—Mitoxantrone—prostate cancer	2.22e-05	0.000139	CcSEcCtD
Sumatriptan—Dermatitis—Mitoxantrone—prostate cancer	2.21e-05	0.000139	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.21e-05	0.000139	CcSEcCtD
Sumatriptan—Headache—Mitoxantrone—prostate cancer	2.2e-05	0.000138	CcSEcCtD
Sumatriptan—Hypotension—Capecitabine—prostate cancer	2.2e-05	0.000138	CcSEcCtD
Sumatriptan—Arthralgia—Prednisone—prostate cancer	2.19e-05	0.000137	CcSEcCtD
Sumatriptan—Myalgia—Prednisone—prostate cancer	2.19e-05	0.000137	CcSEcCtD
Sumatriptan—Paraesthesia—Docetaxel—prostate cancer	2.18e-05	0.000137	CcSEcCtD
Sumatriptan—Anxiety—Prednisone—prostate cancer	2.18e-05	0.000137	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—prostate cancer	2.17e-05	0.000136	CcSEcCtD
Sumatriptan—Dyspnoea—Docetaxel—prostate cancer	2.17e-05	0.000136	CcSEcCtD
Sumatriptan—Somnolence—Docetaxel—prostate cancer	2.16e-05	0.000135	CcSEcCtD
Sumatriptan—Discomfort—Prednisone—prostate cancer	2.16e-05	0.000135	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—prostate cancer	2.16e-05	0.000135	CcSEcCtD
Sumatriptan—Hypersensitivity—Etoposide—prostate cancer	2.15e-05	0.000135	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—prostate cancer	2.15e-05	0.000135	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—prostate cancer	2.15e-05	0.000135	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.14e-05	0.000134	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—prostate cancer	2.14e-05	0.000134	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—prostate cancer	2.13e-05	0.000134	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—prostate cancer	2.12e-05	0.000133	CcSEcCtD
Sumatriptan—Paraesthesia—Capecitabine—prostate cancer	2.11e-05	0.000132	CcSEcCtD
Sumatriptan—Decreased appetite—Docetaxel—prostate cancer	2.11e-05	0.000132	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Docetaxel—prostate cancer	2.1e-05	0.000132	CcSEcCtD
Sumatriptan—Asthenia—Etoposide—prostate cancer	2.1e-05	0.000132	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—prostate cancer	2.1e-05	0.000132	CcSEcCtD
Sumatriptan—Dyspnoea—Capecitabine—prostate cancer	2.1e-05	0.000132	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisone—prostate cancer	2.1e-05	0.000131	CcSEcCtD
Sumatriptan—Oedema—Prednisone—prostate cancer	2.1e-05	0.000131	CcSEcCtD
Sumatriptan—Fatigue—Docetaxel—prostate cancer	2.1e-05	0.000131	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—prostate cancer	2.09e-05	0.000131	CcSEcCtD
Sumatriptan—Nausea—Mitoxantrone—prostate cancer	2.09e-05	0.000131	CcSEcCtD
Sumatriptan—Immune system disorder—Epirubicin—prostate cancer	2.08e-05	0.000131	CcSEcCtD
Sumatriptan—Infection—Prednisone—prostate cancer	2.08e-05	0.000131	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—prostate cancer	2.08e-05	0.00013	CcSEcCtD
Sumatriptan—Constipation—Docetaxel—prostate cancer	2.08e-05	0.00013	CcSEcCtD
Sumatriptan—Pain—Docetaxel—prostate cancer	2.08e-05	0.00013	CcSEcCtD
Sumatriptan—Chills—Epirubicin—prostate cancer	2.07e-05	0.00013	CcSEcCtD
Sumatriptan—Pruritus—Etoposide—prostate cancer	2.07e-05	0.00013	CcSEcCtD
Sumatriptan—Shock—Prednisone—prostate cancer	2.06e-05	0.000129	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—prostate cancer	2.06e-05	0.000129	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—prostate cancer	2.06e-05	0.000129	CcSEcCtD
Sumatriptan—Nervous system disorder—Prednisone—prostate cancer	2.06e-05	0.000129	CcSEcCtD
Sumatriptan—Tachycardia—Prednisone—prostate cancer	2.05e-05	0.000128	CcSEcCtD
Sumatriptan—Decreased appetite—Capecitabine—prostate cancer	2.05e-05	0.000128	CcSEcCtD
Sumatriptan—Skin disorder—Prednisone—prostate cancer	2.04e-05	0.000128	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Capecitabine—prostate cancer	2.03e-05	0.000127	CcSEcCtD
Sumatriptan—Fatigue—Capecitabine—prostate cancer	2.03e-05	0.000127	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisone—prostate cancer	2.03e-05	0.000127	CcSEcCtD
Sumatriptan—Pain—Capecitabine—prostate cancer	2.01e-05	0.000126	CcSEcCtD
Sumatriptan—Constipation—Capecitabine—prostate cancer	2.01e-05	0.000126	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—prostate cancer	2.01e-05	0.000126	CcSEcCtD
Sumatriptan—Feeling abnormal—Docetaxel—prostate cancer	2e-05	0.000126	CcSEcCtD
Sumatriptan—Diarrhoea—Etoposide—prostate cancer	2e-05	0.000125	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—prostate cancer	1.99e-05	0.000125	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—prostate cancer	1.99e-05	0.000125	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Docetaxel—prostate cancer	1.99e-05	0.000125	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—prostate cancer	1.98e-05	0.000124	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—prostate cancer	1.98e-05	0.000124	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—prostate cancer	1.97e-05	0.000123	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—prostate cancer	1.94e-05	0.000122	CcSEcCtD
Sumatriptan—Feeling abnormal—Capecitabine—prostate cancer	1.94e-05	0.000122	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—prostate cancer	1.94e-05	0.000121	CcSEcCtD
Sumatriptan—Dizziness—Etoposide—prostate cancer	1.93e-05	0.000121	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—prostate cancer	1.93e-05	0.000121	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—prostate cancer	1.93e-05	0.000121	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Capecitabine—prostate cancer	1.92e-05	0.000121	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—prostate cancer	1.92e-05	0.000121	CcSEcCtD
Sumatriptan—Body temperature increased—Docetaxel—prostate cancer	1.92e-05	0.00012	CcSEcCtD
Sumatriptan—Abdominal pain—Docetaxel—prostate cancer	1.92e-05	0.00012	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—prostate cancer	1.92e-05	0.00012	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Prednisone—prostate cancer	1.91e-05	0.00012	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—prostate cancer	1.91e-05	0.00012	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisone—prostate cancer	1.88e-05	0.000118	CcSEcCtD
Sumatriptan—Urticaria—Capecitabine—prostate cancer	1.87e-05	0.000117	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—prostate cancer	1.86e-05	0.000117	CcSEcCtD
Sumatriptan—Abdominal pain—Capecitabine—prostate cancer	1.86e-05	0.000117	CcSEcCtD
Sumatriptan—Body temperature increased—Capecitabine—prostate cancer	1.86e-05	0.000117	CcSEcCtD
Sumatriptan—Vomiting—Etoposide—prostate cancer	1.86e-05	0.000117	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—prostate cancer	1.86e-05	0.000117	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—prostate cancer	1.86e-05	0.000116	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—prostate cancer	1.85e-05	0.000116	CcSEcCtD
Sumatriptan—Rash—Etoposide—prostate cancer	1.84e-05	0.000116	CcSEcCtD
Sumatriptan—Dermatitis—Etoposide—prostate cancer	1.84e-05	0.000116	CcSEcCtD
Sumatriptan—Headache—Etoposide—prostate cancer	1.83e-05	0.000115	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—prostate cancer	1.83e-05	0.000115	CcSEcCtD
Sumatriptan—Decreased appetite—Prednisone—prostate cancer	1.82e-05	0.000114	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—prostate cancer	1.82e-05	0.000114	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—prostate cancer	1.81e-05	0.000114	CcSEcCtD
Sumatriptan—Fatigue—Prednisone—prostate cancer	1.81e-05	0.000113	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—prostate cancer	1.8e-05	0.000113	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—prostate cancer	1.8e-05	0.000113	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—prostate cancer	1.8e-05	0.000113	CcSEcCtD
Sumatriptan—Constipation—Prednisone—prostate cancer	1.79e-05	0.000112	CcSEcCtD
Sumatriptan—Hypersensitivity—Docetaxel—prostate cancer	1.79e-05	0.000112	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—prostate cancer	1.79e-05	0.000112	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—prostate cancer	1.77e-05	0.000111	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—prostate cancer	1.77e-05	0.000111	CcSEcCtD
Sumatriptan—Cough—Epirubicin—prostate cancer	1.75e-05	0.00011	CcSEcCtD
Sumatriptan—Asthenia—Docetaxel—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Sumatriptan—Nausea—Etoposide—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Sumatriptan—Hypersensitivity—Capecitabine—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisone—prostate cancer	1.73e-05	0.000108	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—prostate cancer	1.72e-05	0.000108	CcSEcCtD
Sumatriptan—Pruritus—Docetaxel—prostate cancer	1.72e-05	0.000108	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—prostate cancer	1.72e-05	0.000108	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Prednisone—prostate cancer	1.71e-05	0.000107	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—prostate cancer	1.71e-05	0.000107	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—prostate cancer	1.71e-05	0.000107	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—prostate cancer	1.71e-05	0.000107	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—prostate cancer	1.71e-05	0.000107	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—prostate cancer	1.7e-05	0.000107	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—prostate cancer	1.69e-05	0.000106	CcSEcCtD
Sumatriptan—Asthenia—Capecitabine—prostate cancer	1.69e-05	0.000106	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—prostate cancer	1.68e-05	0.000105	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—prostate cancer	1.67e-05	0.000105	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—prostate cancer	1.67e-05	0.000105	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—prostate cancer	1.67e-05	0.000105	CcSEcCtD
Sumatriptan—Urticaria—Prednisone—prostate cancer	1.66e-05	0.000104	CcSEcCtD
Sumatriptan—Pruritus—Capecitabine—prostate cancer	1.66e-05	0.000104	CcSEcCtD
Sumatriptan—Diarrhoea—Docetaxel—prostate cancer	1.66e-05	0.000104	CcSEcCtD
Sumatriptan—Abdominal pain—Prednisone—prostate cancer	1.66e-05	0.000104	CcSEcCtD
Sumatriptan—Body temperature increased—Prednisone—prostate cancer	1.66e-05	0.000104	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—prostate cancer	1.65e-05	0.000104	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—prostate cancer	1.64e-05	0.000103	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—prostate cancer	1.64e-05	0.000103	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—prostate cancer	1.64e-05	0.000103	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—prostate cancer	1.63e-05	0.000102	CcSEcCtD
Sumatriptan—Infection—Epirubicin—prostate cancer	1.63e-05	0.000102	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—prostate cancer	1.62e-05	0.000102	CcSEcCtD
Sumatriptan—Shock—Epirubicin—prostate cancer	1.61e-05	0.000101	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—prostate cancer	1.61e-05	0.000101	CcSEcCtD
Sumatriptan—Diarrhoea—Capecitabine—prostate cancer	1.61e-05	0.000101	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—prostate cancer	1.61e-05	0.000101	CcSEcCtD
Sumatriptan—Dizziness—Docetaxel—prostate cancer	1.61e-05	0.000101	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—prostate cancer	1.6e-05	0.000101	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—prostate cancer	1.6e-05	0.000101	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—prostate cancer	1.6e-05	0.0001	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—prostate cancer	1.59e-05	9.98e-05	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—prostate cancer	1.58e-05	9.94e-05	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—prostate cancer	1.58e-05	9.92e-05	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—prostate cancer	1.58e-05	9.92e-05	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—prostate cancer	1.58e-05	9.92e-05	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—prostate cancer	1.58e-05	9.89e-05	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—prostate cancer	1.56e-05	9.8e-05	CcSEcCtD
Sumatriptan—Dizziness—Capecitabine—prostate cancer	1.56e-05	9.76e-05	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—prostate cancer	1.55e-05	9.7e-05	CcSEcCtD
Sumatriptan—Vomiting—Docetaxel—prostate cancer	1.55e-05	9.69e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisone—prostate cancer	1.54e-05	9.68e-05	CcSEcCtD
Sumatriptan—Rash—Docetaxel—prostate cancer	1.53e-05	9.61e-05	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—prostate cancer	1.53e-05	9.6e-05	CcSEcCtD
Sumatriptan—Dermatitis—Docetaxel—prostate cancer	1.53e-05	9.6e-05	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—prostate cancer	1.53e-05	9.59e-05	CcSEcCtD
Sumatriptan—Headache—Docetaxel—prostate cancer	1.52e-05	9.55e-05	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—prostate cancer	1.52e-05	9.51e-05	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—prostate cancer	1.52e-05	9.51e-05	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—prostate cancer	1.51e-05	9.45e-05	CcSEcCtD
Sumatriptan—Asthenia—Prednisone—prostate cancer	1.5e-05	9.43e-05	CcSEcCtD
Sumatriptan—Vomiting—Capecitabine—prostate cancer	1.5e-05	9.38e-05	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.49e-05	9.36e-05	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—prostate cancer	1.49e-05	9.36e-05	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—prostate cancer	1.49e-05	9.33e-05	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—prostate cancer	1.48e-05	9.31e-05	CcSEcCtD
Sumatriptan—Rash—Capecitabine—prostate cancer	1.48e-05	9.3e-05	CcSEcCtD
Sumatriptan—Pruritus—Prednisone—prostate cancer	1.48e-05	9.3e-05	CcSEcCtD
Sumatriptan—Dermatitis—Capecitabine—prostate cancer	1.48e-05	9.29e-05	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—prostate cancer	1.48e-05	9.28e-05	CcSEcCtD
Sumatriptan—Headache—Capecitabine—prostate cancer	1.47e-05	9.24e-05	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—prostate cancer	1.47e-05	9.24e-05	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—prostate cancer	1.47e-05	9.23e-05	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—prostate cancer	1.47e-05	9.19e-05	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—prostate cancer	1.46e-05	9.16e-05	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—prostate cancer	1.46e-05	9.14e-05	CcSEcCtD
Sumatriptan—Nausea—Docetaxel—prostate cancer	1.44e-05	9.05e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Prednisone—prostate cancer	1.43e-05	8.99e-05	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—prostate cancer	1.42e-05	8.94e-05	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—prostate cancer	1.42e-05	8.89e-05	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—prostate cancer	1.42e-05	8.87e-05	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—prostate cancer	1.41e-05	8.86e-05	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—prostate cancer	1.4e-05	8.79e-05	CcSEcCtD
Sumatriptan—Pain—Epirubicin—prostate cancer	1.4e-05	8.79e-05	CcSEcCtD
Sumatriptan—Nausea—Capecitabine—prostate cancer	1.4e-05	8.76e-05	CcSEcCtD
Sumatriptan—Dizziness—Prednisone—prostate cancer	1.39e-05	8.69e-05	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.38e-05	8.67e-05	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—prostate cancer	1.36e-05	8.54e-05	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—prostate cancer	1.35e-05	8.48e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—prostate cancer	1.35e-05	8.47e-05	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—prostate cancer	1.35e-05	8.46e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—prostate cancer	1.34e-05	8.41e-05	CcSEcCtD
Sumatriptan—Vomiting—Prednisone—prostate cancer	1.33e-05	8.36e-05	CcSEcCtD
Sumatriptan—Rash—Prednisone—prostate cancer	1.32e-05	8.29e-05	CcSEcCtD
Sumatriptan—Dermatitis—Prednisone—prostate cancer	1.32e-05	8.28e-05	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—prostate cancer	1.32e-05	8.27e-05	CcSEcCtD
Sumatriptan—Headache—Prednisone—prostate cancer	1.31e-05	8.23e-05	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.31e-05	8.21e-05	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—prostate cancer	1.31e-05	8.2e-05	CcSEcCtD
Sumatriptan—Urticaria—Epirubicin—prostate cancer	1.3e-05	8.17e-05	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—prostate cancer	1.3e-05	8.13e-05	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—prostate cancer	1.3e-05	8.13e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—prostate cancer	1.3e-05	8.13e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—prostate cancer	1.3e-05	8.13e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—prostate cancer	1.25e-05	7.84e-05	CcSEcCtD
Sumatriptan—Nausea—Prednisone—prostate cancer	1.24e-05	7.81e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—prostate cancer	1.24e-05	7.78e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—prostate cancer	1.21e-05	7.57e-05	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—prostate cancer	1.2e-05	7.56e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—prostate cancer	1.2e-05	7.52e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—prostate cancer	1.2e-05	7.52e-05	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—prostate cancer	1.18e-05	7.37e-05	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—prostate cancer	1.16e-05	7.27e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—prostate cancer	1.12e-05	7.03e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—prostate cancer	1.12e-05	7.01e-05	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—prostate cancer	1.09e-05	6.82e-05	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—prostate cancer	1.08e-05	6.8e-05	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—prostate cancer	1.07e-05	6.73e-05	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—prostate cancer	1.04e-05	6.54e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—prostate cancer	1.04e-05	6.51e-05	CcSEcCtD
Sumatriptan—Rash—Epirubicin—prostate cancer	1.03e-05	6.48e-05	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—prostate cancer	1.03e-05	6.48e-05	CcSEcCtD
Sumatriptan—Headache—Epirubicin—prostate cancer	1.03e-05	6.44e-05	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—prostate cancer	1e-05	6.29e-05	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—prostate cancer	9.74e-06	6.11e-05	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—prostate cancer	9.64e-06	6.05e-05	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—prostate cancer	9.56e-06	6e-05	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—prostate cancer	9.55e-06	5.99e-05	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—prostate cancer	9.5e-06	5.96e-05	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—prostate cancer	9.01e-06	5.65e-05	CcSEcCtD
Sumatriptan—HTR1D—Signaling Pathways—SERPINE1—prostate cancer	3.16e-06	5.16e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CB—prostate cancer	3.16e-06	5.15e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAP2K1—prostate cancer	3.15e-06	5.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LPL—prostate cancer	3.15e-06	5.13e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2E1—prostate cancer	3.13e-06	5.11e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CD—prostate cancer	3.13e-06	5.11e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—prostate cancer	3.13e-06	5.1e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—prostate cancer	3.13e-06	5.1e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—prostate cancer	3.13e-06	5.1e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—prostate cancer	3.12e-06	5.1e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—prostate cancer	3.12e-06	5.09e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDGFRB—prostate cancer	3.12e-06	5.09e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—prostate cancer	3.1e-06	5.06e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NQO1—prostate cancer	3.1e-06	5.05e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SERPINE1—prostate cancer	3.1e-06	5.05e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CD—prostate cancer	3.1e-06	5.05e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CB—prostate cancer	3.09e-06	5.04e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—INS—prostate cancer	3.09e-06	5.03e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HIF1A—prostate cancer	3.08e-06	5.02e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—prostate cancer	3.07e-06	5e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGF2—prostate cancer	3.06e-06	4.99e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—prostate cancer	3.06e-06	4.99e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TH—prostate cancer	3.05e-06	4.98e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ITGB3—prostate cancer	3.04e-06	4.96e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CREBBP—prostate cancer	3.02e-06	4.93e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP3A4—prostate cancer	3.02e-06	4.93e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOS3—prostate cancer	3.02e-06	4.92e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LEP—prostate cancer	3.01e-06	4.9e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGF2—prostate cancer	3e-06	4.89e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CAV1—prostate cancer	2.98e-06	4.86e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1B1—prostate cancer	2.97e-06	4.84e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—prostate cancer	2.97e-06	4.84e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOS3—prostate cancer	2.96e-06	4.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB3—prostate cancer	2.95e-06	4.81e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGFR2—prostate cancer	2.95e-06	4.8e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—prostate cancer	2.94e-06	4.8e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JAK2—prostate cancer	2.93e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CB—prostate cancer	2.92e-06	4.77e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NOS3—prostate cancer	2.92e-06	4.77e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—prostate cancer	2.9e-06	4.73e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—prostate cancer	2.89e-06	4.72e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GGT1—prostate cancer	2.88e-06	4.69e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—prostate cancer	2.88e-06	4.69e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JAK2—prostate cancer	2.87e-06	4.69e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ESR1—prostate cancer	2.87e-06	4.68e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CD—prostate cancer	2.87e-06	4.68e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MDM2—prostate cancer	2.86e-06	4.67e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—prostate cancer	2.84e-06	4.63e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NCOA1—prostate cancer	2.83e-06	4.62e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—prostate cancer	2.83e-06	4.61e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB2—prostate cancer	2.82e-06	4.61e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—prostate cancer	2.82e-06	4.59e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MDM2—prostate cancer	2.8e-06	4.57e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BAD—prostate cancer	2.8e-06	4.57e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP19A1—prostate cancer	2.79e-06	4.55e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CB—prostate cancer	2.79e-06	4.54e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB2—prostate cancer	2.77e-06	4.51e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CB—prostate cancer	2.73e-06	4.45e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—prostate cancer	2.73e-06	4.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CG—prostate cancer	2.71e-06	4.42e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APC—prostate cancer	2.71e-06	4.42e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NOS3—prostate cancer	2.71e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HIF1A—prostate cancer	2.7e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CB—prostate cancer	2.7e-06	4.4e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—RXRA—prostate cancer	2.7e-06	4.4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGF—prostate cancer	2.68e-06	4.37e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IRS1—prostate cancer	2.68e-06	4.37e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—prostate cancer	2.68e-06	4.37e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—prostate cancer	2.67e-06	4.36e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—prostate cancer	2.66e-06	4.33e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LEP—prostate cancer	2.64e-06	4.3e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—prostate cancer	2.62e-06	4.28e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1B—prostate cancer	2.62e-06	4.26e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CAV1—prostate cancer	2.61e-06	4.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GSK3B—prostate cancer	2.6e-06	4.25e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—EP300—prostate cancer	2.6e-06	4.24e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—COMT—prostate cancer	2.6e-06	4.23e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—prostate cancer	2.59e-06	4.22e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—prostate cancer	2.59e-06	4.22e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—prostate cancer	2.58e-06	4.21e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—prostate cancer	2.57e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—INS—prostate cancer	2.57e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—prostate cancer	2.56e-06	4.18e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1B—prostate cancer	2.56e-06	4.18e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—prostate cancer	2.56e-06	4.17e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—prostate cancer	2.55e-06	4.15e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ITPR1—prostate cancer	2.54e-06	4.15e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—prostate cancer	2.53e-06	4.13e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—prostate cancer	2.53e-06	4.12e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ESR1—prostate cancer	2.52e-06	4.11e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CREBBP—prostate cancer	2.52e-06	4.1e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—prostate cancer	2.51e-06	4.09e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—prostate cancer	2.51e-06	4.09e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CB—prostate cancer	2.5e-06	4.08e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—prostate cancer	2.5e-06	4.07e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—prostate cancer	2.49e-06	4.07e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—prostate cancer	2.48e-06	4.05e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—prostate cancer	2.48e-06	4.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—prostate cancer	2.47e-06	4.03e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CTNNB1—prostate cancer	2.47e-06	4.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BAD—prostate cancer	2.46e-06	4.01e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—prostate cancer	2.44e-06	3.98e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—prostate cancer	2.42e-06	3.95e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CTNNB1—prostate cancer	2.42e-06	3.95e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1A—prostate cancer	2.41e-06	3.94e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—EP300—prostate cancer	2.41e-06	3.93e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—prostate cancer	2.41e-06	3.93e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TYMS—prostate cancer	2.4e-06	3.92e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAP2K1—prostate cancer	2.4e-06	3.91e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CD—prostate cancer	2.38e-06	3.89e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APC—prostate cancer	2.38e-06	3.88e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CG—prostate cancer	2.38e-06	3.88e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—prostate cancer	2.37e-06	3.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—prostate cancer	2.37e-06	3.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1A—prostate cancer	2.36e-06	3.85e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—prostate cancer	2.36e-06	3.85e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SERPINE1—prostate cancer	2.36e-06	3.85e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—prostate cancer	2.36e-06	3.85e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGF—prostate cancer	2.35e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IRS1—prostate cancer	2.35e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—prostate cancer	2.35e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—prostate cancer	2.35e-06	3.83e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—prostate cancer	2.33e-06	3.81e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—prostate cancer	2.33e-06	3.8e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—LPL—prostate cancer	2.33e-06	3.8e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—prostate cancer	2.3e-06	3.75e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EP300—prostate cancer	2.3e-06	3.75e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GSK3B—prostate cancer	2.29e-06	3.73e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGF2—prostate cancer	2.28e-06	3.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—INS—prostate cancer	2.25e-06	3.68e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOS3—prostate cancer	2.25e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1A1—prostate cancer	2.25e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EP300—prostate cancer	2.25e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SRC—prostate cancer	2.23e-06	3.64e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ERCC2—prostate cancer	2.23e-06	3.64e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—EP300—prostate cancer	2.22e-06	3.63e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CREBBP—prostate cancer	2.21e-06	3.6e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JAK2—prostate cancer	2.19e-06	3.57e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SRC—prostate cancer	2.19e-06	3.57e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—prostate cancer	2.18e-06	3.56e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—prostate cancer	2.18e-06	3.55e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—prostate cancer	2.17e-06	3.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—prostate cancer	2.17e-06	3.54e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—prostate cancer	2.16e-06	3.52e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—prostate cancer	2.15e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	2.15e-06	3.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MDM2—prostate cancer	2.14e-06	3.48e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—prostate cancer	2.13e-06	3.47e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—prostate cancer	2.11e-06	3.44e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAP2K1—prostate cancer	2.11e-06	3.44e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB2—prostate cancer	2.11e-06	3.43e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—prostate cancer	2.1e-06	3.42e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CD—prostate cancer	2.09e-06	3.41e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	2.08e-06	3.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	2.07e-06	3.38e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SERPINE1—prostate cancer	2.07e-06	3.38e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—EP300—prostate cancer	2.06e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARA—prostate cancer	2.06e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—prostate cancer	2.05e-06	3.34e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGF2—prostate cancer	2e-06	3.27e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—prostate cancer	2e-06	3.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—prostate cancer	2e-06	3.26e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—prostate cancer	2e-06	3.26e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOS3—prostate cancer	1.98e-06	3.22e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—prostate cancer	1.96e-06	3.2e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—prostate cancer	1.96e-06	3.19e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—prostate cancer	1.95e-06	3.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	1.95e-06	3.18e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAV1—prostate cancer	1.94e-06	3.16e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	1.93e-06	3.15e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.92e-06	3.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JAK2—prostate cancer	1.92e-06	3.13e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—prostate cancer	1.92e-06	3.13e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—prostate cancer	1.91e-06	3.12e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—prostate cancer	1.91e-06	3.11e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—prostate cancer	1.9e-06	3.1e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	1.88e-06	3.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MDM2—prostate cancer	1.88e-06	3.06e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—prostate cancer	1.86e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB2—prostate cancer	1.85e-06	3.02e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—prostate cancer	1.85e-06	3.02e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	1.84e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CB—prostate cancer	1.83e-06	2.98e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—prostate cancer	1.81e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—prostate cancer	1.81e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	1.8e-06	2.94e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—prostate cancer	1.8e-06	2.93e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—prostate cancer	1.78e-06	2.91e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CG—prostate cancer	1.76e-06	2.88e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—prostate cancer	1.75e-06	2.86e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—prostate cancer	1.75e-06	2.86e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EP300—prostate cancer	1.71e-06	2.79e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1B—prostate cancer	1.71e-06	2.79e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—prostate cancer	1.7e-06	2.77e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.69e-06	2.76e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—prostate cancer	1.68e-06	2.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—prostate cancer	1.68e-06	2.73e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—INS—prostate cancer	1.67e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—prostate cancer	1.67e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SRC—prostate cancer	1.67e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	1.66e-06	2.71e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.65e-06	2.68e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—prostate cancer	1.64e-06	2.68e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CREBBP—prostate cancer	1.63e-06	2.67e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—prostate cancer	1.63e-06	2.66e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—prostate cancer	1.62e-06	2.65e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.62e-06	2.64e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—prostate cancer	1.61e-06	2.62e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—prostate cancer	1.61e-06	2.62e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—prostate cancer	1.59e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.58e-06	2.58e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—prostate cancer	1.58e-06	2.57e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—prostate cancer	1.57e-06	2.56e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CD—prostate cancer	1.55e-06	2.53e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.54e-06	2.51e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—prostate cancer	1.52e-06	2.48e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—prostate cancer	1.5e-06	2.45e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EP300—prostate cancer	1.5e-06	2.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—prostate cancer	1.49e-06	2.43e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.49e-06	2.43e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—prostate cancer	1.47e-06	2.4e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NOS3—prostate cancer	1.46e-06	2.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SRC—prostate cancer	1.46e-06	2.39e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.46e-06	2.38e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—prostate cancer	1.46e-06	2.37e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.42e-06	2.32e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—prostate cancer	1.41e-06	2.3e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—prostate cancer	1.39e-06	2.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.38e-06	2.25e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—prostate cancer	1.36e-06	2.22e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CB—prostate cancer	1.35e-06	2.2e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—prostate cancer	1.34e-06	2.19e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—prostate cancer	1.34e-06	2.18e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—prostate cancer	1.31e-06	2.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.31e-06	2.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—prostate cancer	1.28e-06	2.09e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.27e-06	2.07e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—prostate cancer	1.24e-06	2.03e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—prostate cancer	1.23e-06	2e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—prostate cancer	1.21e-06	1.97e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—prostate cancer	1.17e-06	1.9e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—prostate cancer	1.12e-06	1.83e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—EP300—prostate cancer	1.11e-06	1.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.11e-06	1.81e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—prostate cancer	1.08e-06	1.76e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—prostate cancer	1.04e-06	1.69e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—prostate cancer	9.85e-07	1.61e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—prostate cancer	9.09e-07	1.48e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—prostate cancer	8.24e-07	1.34e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—prostate cancer	6.73e-07	1.1e-05	CbGpPWpGaD
